Kelley MC - Search Results

1

Long-Term Survival after Complete Surgical Resection and Adjuvant Immunotherapy for Distant Melanoma Metastases.

Faries MB, Mozzillo N, Kashani-Sabet M, Thompson JF, Kelley MC, DeConti RC, Lee JE, Huth JF, Wagner J, Dalgleish A, Pertschuk D, Nardo C, Stern S, Elashoff R, Gammon G, Morton DL; MMAIT-IV Clinical Trial Group. Faries MB, et al. Among authors: kelley mc. Ann Surg Oncol. 2017 Dec;24(13):3991-4000. doi: 10.1245/s10434-017-6072-3. Epub 2017 Oct 10. Ann Surg Oncol. 2017. PMID: 29019177 Clinical Trial.

2

Immune response to polyvalent melanoma cell vaccine in AJCC stage III melanoma: an immunologic survival model.

Jones RC, Kelley M, Gupta RK, Nizze JA, Yee R, Leopoldo Z, Qi K, Stern S, Morton DL. Jones RC, et al. Ann Surg Oncol. 1996 Sep;3(5):437-45. doi: 10.1007/BF02305761. Ann Surg Oncol. 1996. PMID: 8876885

3

Cellular cancer vaccine induces delayed-type hypersensitivity reaction and augments antibody response to tumor-associated carbohydrate antigens (sialyl Le(a), sialyl Le(x), GD3 and GM2) better than soluble lysate cancer vaccine.

Ravindranath MH, Bauer PM, Amiri AA, Miri SM, Kelley MC, Jones RC, Morton DL. Ravindranath MH, et al. Among authors: kelley mc. Anticancer Drugs. 1997 Mar;8(3):217-24. doi: 10.1097/00001813-199703000-00001. Anticancer Drugs. 1997. PMID: 9095325

4

Endothelial-selectin ligands sialyl Lewis(x) and sialyl Lewis(a) are differentiation antigens immunogenic in human melanoma.

Ravindranath MH, Amiri AA, Bauer PM, Kelley MC, Essner R, Morton DL. Ravindranath MH, et al. Among authors: kelley mc. Cancer. 1997 May 1;79(9):1686-97. doi: 10.1002/(sici)1097-0142(19970501)79:9<1686::aid-cncr8>3.0.co;2-a. Cancer. 1997. PMID: 9128983

5

Update on active specific immunotherapy with melanoma vaccines.

Conforti AM, Ollila DW, Kelley MC, Gammon G, Morton DL. Conforti AM, et al. Among authors: kelley mc. J Surg Oncol. 1997 Sep;66(1):55-64. doi: 10.1002/(sici)1096-9098(199709)66:1<55::aid-jso12>3.0.co;2-n. J Surg Oncol. 1997. PMID: 9290695 Review.

6

Intraoperative lymphatic mapping for early-stage melanoma of the head and neck.

Bostick P, Essner R, Sarantou T, Kelley M, Glass E, Foshag L, Stern S, Morton D. Bostick P, et al. Am J Surg. 1997 Nov;174(5):536-9. doi: 10.1016/S0002-9610(97)00150-5. Am J Surg. 1997. PMID: 9374232

7

Ratio of IgG:IgM antibodies to sialyl Lewis(x) and GM3 correlates with tumor growth after immunization with melanoma-cell vaccine with different adjuvants in mice.

Ravindranath MH, Kelley MC, Jones RC, Amiri AA, Bauer PM, Morton DL. Ravindranath MH, et al. Among authors: kelley mc. Int J Cancer. 1998 Jan 5;75(1):117-24. doi: 10.1002/(sici)1097-0215(19980105)75:1<117::aid-ijc18>3.0.co;2-d. Int J Cancer. 1998. PMID: 9426699 Free article.

8

Lymphatic mapping and sentinel lymphadenectomy for melanoma.

Kelley MC, Ollila DW, Morton DL. Kelley MC, et al. Semin Surg Oncol. 1998 Jun;14(4):283-90. doi: 10.1002/(sici)1098-2388(199806)14:4<283::aid-ssu4>3.0.co;2-z. Semin Surg Oncol. 1998. PMID: 9588721 Review.

9

Overview of melanoma vaccines: active specific immunotherapy for melanoma patients.

Ollila DW, Kelley MC, Gammon G, Morton DL. Ollila DW, et al. Among authors: kelley mc. Semin Surg Oncol. 1998 Jun;14(4):328-36. doi: 10.1002/(sici)1098-2388(199806)14:4<328::aid-ssu9>3.0.co;2-4. Semin Surg Oncol. 1998. PMID: 9588726 Review.

10

Tumor-associated antigen TA-90 immune complex assay predicts subclinical metastasis and survival for patients with early stage melanoma.

Kelley MC, Jones RC, Gupta RK, Yee R, Stern S, Wanek L, Morton DL. Kelley MC, et al. Cancer. 1998 Oct 1;83(7):1355-61. doi: 10.1002/(sici)1097-0142(19981001)83:7<1355::aid-cncr12>3.0.co;2-3. Cancer. 1998. PMID: 9762936

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

120 results

Search Page